Daily Briefing for October 29, 2026
Physician in the Loop · Oct 29, 2026 · 4:26
Physician in the Loop · Oct 29, 2026 · 4:26
Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Kennedy lets doctors compound six unapproved peptides, including BPC-157
The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source.
Federal health officials will not take enforcement action against licensed physicians and state-licensed pharmacies that compound six unapproved peptides, including BPC-157 and TB-500, under a policy Health and Human Services posted Wednesday.
The policy requires a patient-specific prescription, bulk ingredients from an FDA-registered manufacturer with a certificate of analysis, a single active ingredient and reporting of serious adverse events to MedWatch, according to the HHS policy document. The FDA had previously advised people not to use the peptides, The Independent reported.
In other news, emergency physicians at 20 departments spent 2.4 fewer minutes on each note when they used an AI scribe, and Eli Lilly's investigational retatrutide produced more than twice the weight loss of Ozempic in a head-to-head type 2 diabetes trial.
In this episode
Episodes: Physician in the Loop
